News Room
Stay up-to-date with the latest news from Repligen, including company announcements, product launches, industry insights, and upcoming events. Explore how we’re advancing innovation in bioprocessing and shaping the future of therapeutic manufacturing.
News
May 19, 2021
Coronavirus Spike Protein Captures Resin Available for Future Deployment
GEN
News
February 12, 2021
New Affinity Resin for COVID-19 Vaccine Purification
GEN
News
February 10, 2021
Repligen and Navigo target next-wave COVID vaccines with affinity resin
Dan Stanton BioProcess International
Announcements
February 8, 2021
Repligen and Navigo Proteins Announce the Launch of an Affinity Resin for the Purification of COVID-19 Vaccines
News
December 17, 2020
America's Best Mid-size Companies
Andrea Murphy, Hank Tucker Forbes
News
November 19, 2020
Repligen CEO Tony Hunt Knows Why Success Takes Time
Marilyn Munch Investor's Business Daily
News
October 28, 2020
Repligen strengthens downstream offering with $200m ARTeSYN acquisition
Dan Stanton BioProcess International
Announcements
October 27, 2020
Repligen Corporation Announces Agreement to Acquire Bioprocess Systems Innovator ARTeSYN Biosolutions and Completes Acquisition of Non-Metallic Solutions
News
October 8, 2020
Navigo and Repligen Team on COVID-19 Vaccine Affinity Resin
Dan Stanton BioProcess International
Announcements
October 1, 2020
Repligen and Navigo Proteins Announce Achievement of Key Milestone in Developing an Affinity Resin for the Purification of COVID-19 Vaccines
News
September 1, 2020
Continuous Processing: A Step on the Way to Bioprocess 4.0
Gareth John Macdonald GEN
News
July 1, 2020
Repligen boosting single-use portfolio with Engineered Molding Technology buy
BPI Staff BioProcess International